3LNJ | Ligase Ligase Inhibitor | date | Feb 02, 2010 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Crystal Structure Of Human Mdm2 In Complex With D-Peptide In (Dpmi-Alpha) | ||||||||||||||
authors | M.Pazgier, W.Lu | ||||||||||||||
compound | source | ||||||||||||||
Molecule: E3 Ubiquitin-Protein Ligase Mdm2 Chain: A, C, E Fragment: Unp Residues 25-109, P53 Binding Domain Synonym: P53-Binding Protein Mdm2, Oncoprotein Mdm2, Double Protein, Hdm2; Ec: 6.3.2.- Engineered: Yes |
Synthetic: Yes Other_details: Mdm2 Sequence Occurs Naturally In Humans. | ||||||||||||||
Molecule: D-Peptide Inhibitor Chain: B, D, F Engineered: Yes |
Synthetic: Yes Other_details: Synthetic Peptide, D-Enantiomer Of Phage-Sel Peptide | ||||||||||||||
symmetry | Space Group: C 2 2 21 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.40 Å | ||||||||||||
ligand | CL, DAL, DAR, DGL, DLE, DLY, DSG, DTR, DTY, GOL, SO4 | enzyme | Ligase E.C.6.3.2 BRENDA | ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | A left-handed solution to peptide inhibition of the p53-MDM2 interaction., Liu M, Pazgier M, Li C, Yuan W, Li C, Lu W, Angew Chem Int Ed Engl. 2010 May 10;49(21):3649-52. PMID:20449836 |
Data retrieval |
View 3LNJ in 3D |
Visual 3D analysis of 3LNJ |
Structure-derived information |
Sequence-derived information |
Other resources with information on 3LNJ |
Movements, Movies and Images |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |